As millions lose weight on GLP-1s, they're starting to turn to retailers to refresh their wardrobes

Bernstein estimates GLP-1 drugs could boost apparel retail spending by up to $13 billion annually. The analyst note implies a meaningful revenue upside for apparel companies and could support modest stock re-ratings (potentially 1-3%) for retailers exposed to discretionary and fashion categories. The projection is analyst-driven and remains contingent on observed sales trends at the company level.

Analysis

Bernstein estimates GLP-1 drugs could boost apparel retail spending by up to $13 billion annually. The analyst note implies a meaningful revenue upside for apparel companies and could support modest stock re-ratings (potentially 1-3%) for retailers exposed to discretionary and fashion categories. The projection is analyst-driven and remains contingent on observed sales trends at the company level.